1. Home
  2. KLXE vs IBIO Comparison

KLXE vs IBIO Comparison

Compare KLXE & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLXE
  • IBIO
  • Stock Information
  • Founded
  • KLXE 2018
  • IBIO 2008
  • Country
  • KLXE United States
  • IBIO United States
  • Employees
  • KLXE N/A
  • IBIO N/A
  • Industry
  • KLXE Oilfield Services/Equipment
  • IBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • KLXE Energy
  • IBIO Health Care
  • Exchange
  • KLXE Nasdaq
  • IBIO Nasdaq
  • Market Cap
  • KLXE 29.1M
  • IBIO 24.3M
  • IPO Year
  • KLXE N/A
  • IBIO N/A
  • Fundamental
  • Price
  • KLXE $1.78
  • IBIO $0.76
  • Analyst Decision
  • KLXE Hold
  • IBIO Strong Buy
  • Analyst Count
  • KLXE 1
  • IBIO 3
  • Target Price
  • KLXE $4.50
  • IBIO $4.87
  • AVG Volume (30 Days)
  • KLXE 282.6K
  • IBIO 1.2M
  • Earning Date
  • KLXE 05-08-2025
  • IBIO 05-12-2025
  • Dividend Yield
  • KLXE N/A
  • IBIO N/A
  • EPS Growth
  • KLXE N/A
  • IBIO N/A
  • EPS
  • KLXE N/A
  • IBIO N/A
  • Revenue
  • KLXE $709,300,000.00
  • IBIO $375,000.00
  • Revenue This Year
  • KLXE $2.03
  • IBIO $36.00
  • Revenue Next Year
  • KLXE $4.88
  • IBIO $33.33
  • P/E Ratio
  • KLXE N/A
  • IBIO N/A
  • Revenue Growth
  • KLXE N/A
  • IBIO 650.00
  • 52 Week Low
  • KLXE $1.51
  • IBIO $0.87
  • 52 Week High
  • KLXE $7.66
  • IBIO $6.89
  • Technical
  • Relative Strength Index (RSI)
  • KLXE 31.63
  • IBIO 19.10
  • Support Level
  • KLXE $1.64
  • IBIO $0.64
  • Resistance Level
  • KLXE $1.93
  • IBIO $1.00
  • Average True Range (ATR)
  • KLXE 0.29
  • IBIO 0.32
  • MACD
  • KLXE 0.02
  • IBIO -0.10
  • Stochastic Oscillator
  • KLXE 15.79
  • IBIO 3.55

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Share on Social Networks: